Hochschulschrift
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
- Weitere Titel
-
Schutz vor Infektion mit dem Cytomegalievirus durch glykoproteinspezifische monoklonale Antikörper
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Universität Erlangen-Nürnberg, Diss., 2012
- Schlagwort
-
Cytomegalie-Virus ; Antikörper ; Impfung
Infektion
Infektiologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Universitätsbibliothek der Universität Erlangen-Nürnberg
- (wann)
-
2013
- Urheber
-
Karbach, Astrid
- Beteiligte Personen und Organisationen
-
Winkler, Thomas
- URN
-
urn:nbn:de:bvb:29-opus-48913
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.01.20252025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Karbach, Astrid
- Winkler, Thomas
- Universitätsbibliothek der Universität Erlangen-Nürnberg
Entstanden
- 2013
Ähnliche Objekte (12)
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Self-interaction and targeted engineering of monoclonal antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Self-interaction and targeted engineering of monoclonal antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11